Josef Korbinian Vogt

Josef Korbinian Vogt

Auto-generated profile, based on publicly available information

Josef Korbinian Vogt

Clinical Microbiomics, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2013 in Nature
Verified
Journal Article
Closed access
PDF file
LOLudovic Orlando
Ludovic Orlando
AGAurélien Ginolhac
Aurélien Ginolhac
GZGuojie Zhang
Guojie Zhang
DFDuane Froese
Duane Froese
AAAnders Albrechtsen
Anders Albrechtsen
EWEske Willerslev
Eske Willerslev

20 May 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DNDaniela Nitsch
Daniela Nitsch
LTLéon-Charles Tranchevent
Léon-Charles Tranchevent
JGJoana P. Gonçalves
Joana P. Gonçalves
JVJosef Korbinian Vogt
Josef Korbinian Vogt
SMSara C Madeira
Sara C Madeira
YMYves Moreau
Yves Moreau
PINTA (available at http://www.esat.kuleuven.be/pinta/ ; this web site is free and open to all users and there is no login requirement) is a web resource for the prioritization of candidate genes based on the differential expression of their neighborhood in a genome-wide protein–protein interaction network. Our strategy is meant for biological and medical researchers aiming at identifying novel disease genes using disease specific expression data. PINTA supports both candidate gene prioritization (starting from a user defined set of candidate genes) as well as genome-wide gene prioritization and is available for five species (human, mouse, rat, worm and yeast). As input data, PINTA only requires disease specific expression data, whereas various platforms (e.g. Affymetrix) are supported. As a result, PINTA computes a gene ranking and presents the results as a table that can easily be browsed and downloaded by the user.

27 November 2023 in Gut Microbes
Verified
Journal Article
Open access
RLRaakel Luoto
Raakel Luoto
APAnna Pärtty
Anna Pärtty
JVJosef K. Vogt
Josef K. Vogt
SRSamuli Rautava
Samuli Rautava
EIErika Isolauri
Erika Isolauri
The aim of this study was to obtain insight into the composition and function of the deviant gut microbiome throughout infancy in children born moderately and late preterm and their response to microbiome modulation. We characterized the longitudinal development of the gut microbiome from birth to the age of 12 months by metagenomic sequencing in 43 moderate and late preterm children participating in a randomized, controlled trial (ClinicalTrials.gov/no.NCT00167700) assessing the impact of a probiotic (Lactobacillus rhamnosus GG, ATCC 53,103, currently Lacticaseibacillus rhamnosus GG) and a prebiotic (galacto-oligosaccharide and polydextrose mixture, 1:1) intervention as compared to a placebo administered from 3 to 60 days of life. In addition, 9 full-term, vaginally delivered, breast-fed infants, who remained healthy long-term were included as references. Significant differences in taxonomy, but not in functional potential, were found when comparing the gut microbiome composition of preterm and full-term infants during the first month of life. However, the gut microbiome of preterm infants resembled that of full-term infants by 6 months age. Probiotic and prebiotic treatments were found to mitigate the shift in the microbiome of preterm infants by accelerating Bifidobacteria-dominated gut microbiome in beta diversity analysis. This study provides intriguing information regarding the establishment of the gut microbiome in children born moderately and late preterm, representing the majority of children born preterm. Specific pro- and prebiotics may reverse the proinflammatory gut microbiome composition during the vulnerable period, when the microbiome is low in resilience and susceptible to environmental exposure and simultaneously promotes immunological and metabolic maturation.

17 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MJMichael Krogh Jensen
Michael Krogh Jensen
JVJosef Korbinian Vogt
Josef Korbinian Vogt
SBSimon Bressendorff
Simon Bressendorff
ASAndaine Seguin-Orlando
Andaine Seguin-Orlando
MPMorten Petersen
Morten Petersen
JMJohn Mundy
John Mundy
The insectivorous Venus flytrap (Dionaea muscipula) is renowned from Darwin’s studies of plant carnivory and the origins of species. To provide tools to analyze the evolution and functional genomics of D. muscipula, we sequenced a normalized cDNA library synthesized from mRNA isolated from D. muscipula flowers and traps. Using the Oases transcriptome assembler 79,165,657 quality trimmed reads were assembled into 80,806 cDNA contigs, with an average length of 679 bp and an N50 length of 1,051 bp. A total of 17,047 unique proteins were identified, and assigned to Gene Ontology (GO) and classified into functional categories. A total of 15,547 full-length cDNA sequences were identified, from which open reading frames were detected in 10,941. Comparative GO analyses revealed that D. muscipula is highly represented in molecular functions related to catalytic, antioxidant, and electron carrier activities. Also, using a single copy sequence PCR-based method, we estimated that the genome size of D. muscipula is approx. 3 Gb. Our genome size estimate and transcriptome analyses will contribute to future research on this fascinating, monotypic species and its heterotrophic adaptations.

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
PRPaula Rodriguez
Paula Rodriguez
JVJosef K. Vogt
Josef K. Vogt
NSNadja B. S⊘Ndertoft
Nadja B. S⊘Ndertoft
TPThomas N. Petersen
Thomas N. Petersen
OPOluf Pedersen
Oluf Pedersen